文献速递造血干细胞移植与细胞治疗

PTCy通过恢复调节性与效应性T细胞稳态改善PD-1阻断受者GVHD

PTCy ameliorates GVHD by restoring regulatory and effector T-cell homeostasis in recipients with PD-1 blockade.
PubMed 文献 · Blood Adv · 2019-01-01

该研究在小鼠模型中探究供者T细胞PD-1表达对T细胞重建和GVHD的影响,发现PD-1信号抑制导致CD4+常规T细胞过度扩增而Treg因高凋亡易感性不能维持扩增,引起免疫重建失衡和严重GVHD;移植后环磷酰胺(PTCy)可安全调节T细胞亚群增殖与凋亡,恢复Treg持续增殖能力,改善PD-1-/-供者移植后的GVHD并延长总生存。

要点

  • PD-1阻断使CD4+常规T细胞扩增而Treg凋亡易感,导致T细胞重建失衡和严重GVHD。
  • PTCy可调节T细胞亚群增殖与凋亡,恢复Treg持续增殖并平衡供者T细胞重建。
  • PTCy改善PD-1-/-供者移植后GVHD并延长总生存。

核心结论

  • PD-1阻断对T细胞各亚群影响不同,导致T细胞亚群重建失衡并引起严重GVHD。
  • PTCy成功恢复T细胞稳态并改善PD-1-/-供者T细胞诱导的GVHD。

研究设计与样本

  • 采用小鼠模型研究供者T细胞PD-1表达对T细胞重建和GVHD的影响。
  • 评估移植后环磷酰胺(PTCy)对PD-1阻断后异常T细胞重建的作用。

主要发现

  • 抑制PD-1信号诱导CD4+常规T细胞 aggressive 扩增,但Treg因高凋亡易感性不能维持扩增,导致免疫恢复不一致并后续发生严重GVHD。
  • PTCy有效改善PD-1-/-供者移植后的GVHD,并通过安全调节T细胞亚群增殖与凋亡延长总生存。
  • 给予PTCy后前2周内,Treg恢复持续增殖能力,供者T细胞亚群重建良好平衡。

临床怎么用

  • 研究结果可能有助于解释PTCy可减轻既往PD-1阻断相关GVHD发生率和影响的观察现象。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Graft-versus-host disease (GVHD) after allogeneic hematopoietic stem cell transplantation (allo-HSCT) is a significant cause of morbidity and mortality. Regulatory T cells (Tregs) are critical mediators of immune tolerance after allo-HSCT. Clinical studies have indicated that programmed cell death 1 (PD-1) blockade before allo-HSCT involves a risk of severe GVHD. However, the mechanisms underlying GVHD induction resulting from PD-1 blockade remain unclear. We investigated the impact of PD-1 expression of donor T cells on T-cell reconstitution and GVHD using murine models. We first demonstrated that inhibition of PD-1 signaling induced aggressive expansion of CD4+ conventional T cells; however, Tregs could not maintain expansion because of high susceptibility to apoptosis, resulting in discordant immune recovery and subsequent development of severe GVHD. We then evaluated the impact of posttransplantation cyclophosphamide (PTCy) on abnormal T-cell reconstitution after PD-1 blockade. PTCy efficiently ameliorated GVHD after transplantation from a PD-1-/- donor and extended overall survival by safely regulating the proliferation and apoptosis of T-cell subsets. Notably, in the first 2 weeks after administration of PTCy, Tregs regained their ability to continuously proliferate, resulting in well-balanced reconstitution of donor T-cell subsets. In conclusion, the influence of PD-1 blockade differed within T-cell subsets and caused unbalanced reconstitution of T-cell subsets, resulting in severe GVHD. PTCy successfully restored T-cell homeostasis and ameliorated GVHD induced by PD-1-/- donor T cells. These findings may help explain the pathophysiology behind the observation that PTCy may mitigate the incidence and impact of GVHD associated with prior exposure to PD-1 blockade.

来源:Blood Adv,查看原文。版权归原作者所有。

引用

  1. Ikegawa S, Meguri Y, Kondo T, et al. PTCy ameliorates GVHD by restoring regulatory and effector T-cell homeostasis in recipients with PD-1 blockade. Blood Adv. 2019. PMID: 31821459. doi:10.1182/bloodadvances.2019000134

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。